Mc Clarren Financial Advisors, Inc. Bristol Myers Squibb CO Transaction History

Mc Clarren Financial Advisors, Inc.

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 26, 2024	SELL	$40.25 - $52.99 $63,675 - $83,830	-1,582 Reduced 95.02%	83 $69,000
Q1 2024 Jul 26, 2024	BUY	$47.98 - $54.4 $79,886 - $90,576	1,665 New	1,665 $91,000
Q4 2023 Feb 02, 2024	BUY	$48.48 - $57.85 $76,695 - $91,518	1,582 Added 532.66%	1,879 $96,000
Q3 2023 Nov 03, 2023	BUY	$57.89 - $64.73 $173 - $194	3 Added 1.02%	297 $17,000
Q2 2023 Aug 04, 2023	SELL	$63.71 - $70.74 $19,240 - $21,363	-302 Reduced 50.67%	294 $18,000
Q1 2023 May 05, 2023	BUY	$65.71 - $74.53 $262 - $298	4 Added 0.68%	596 $40,000
Q4 2022 Jan 30, 2023	BUY	$68.48 - $81.09 $273 - $324	4 Added 0.68%	592 $42,000
Q3 2022 Oct 31, 2022	BUY	$0.13 - $76.84 $76 - $45,181	588 New	588 $41,000
Q2 2022 Aug 11, 2022	SELL	$72.62 - $79.98 $20,551 - $22,634	-283 Closed	0 $0
Q1 2022 Apr 29, 2022	BUY	$61.48 - $73.72 $61 - $73	1 Added 0.35%	283 $20,000
Q4 2021 Jan 19, 2022	BUY	$53.63 - $62.52 $160 - $187	3 Added 1.08%	282 $18,000
Q3 2021 Oct 15, 2021	SELL	$59.17 - $69.31 $11,478 - $13,446	-194 Reduced 41.01%	279 $16,000
Q2 2021 Jul 23, 2021	BUY	$61.91 - $67.42 $14,920 - $16,248	241 Added 103.88%	473 $31,000
Q1 2021 Apr 21, 2021	BUY	$59.34 - $66.74 $59 - $66	1 Added 0.43%	232 $15,000
Q4 2020 Jan 29, 2021	BUY	$57.74 - $65.43 $13,337 - $15,114	231 New	231 $14,000

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $124B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Mc Clarren Financial Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Mc Clarren Financial Advisors, Inc. with notifications on news.